Analysis of patients with two hereditary cancers (breast/ovarian or colon/endometrial) who met NCCN genetic testing criteria after their first cancer.

被引：0

作者：

Saam, Jennifer ^{[1
]}

Moyes, Kelsey ^{[1
]}

Arnell, Christopher ^{[1
]}

Landon, Michelle ^{[1
]}

Kaldate, Rajesh R. ^{[1
]}

Strike, Brian ^{[1
]}

Williams, Kayon ^{[1
]}

Burbidga, Lynn Anna ^{[1
]}

Abbott, Brian ^{[1
]}

机构：

[1] Myriad Genet Labs Inc, Salt Lake City, UT USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.1542

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1542

引用

页数：1

共 50 条

[31] Uptake of Cascade Genetic Testing for Hereditary Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis
Ahsan, Muhammad Danyal
Chandler, Isabelle R.
Min, Samantha
Grant, Benjamin
Primiano, Michelle
Greenwald, Jamieson
Soussana, Tamar N.
Baltich Nelson, Becky
Thomas, Charlene
Chapman-Davis, Eloise
Sharaf, Ravi N.
Frey, Melissa K.
CLINICAL OBSTETRICS AND GYNECOLOGY, 2024, 67 (04): : 702 - 710
[32] Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
Cropper, Caiqian
Woodson, Ashley
Arun, Banu
Barcenas, Carlos
Litton, Jennifer
Noblin, Sarah
Liu, Diane
Park, Minjeong
Daniels, Molly
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (06): : 797 - 803
[33] A mixed methods analysis of patient- and provider-perceived barriers and facilitators to cascade genetic testing for hereditary breast, ovarian, endometrial and colorectal cancer
Stock, Elizabeth
Walsh-Bailey, Callie
Tuda, Daniela
Tabak, Rachel
Baumann, Ana
Hagemann, Andrea
GYNECOLOGIC ONCOLOGY, 2023, 176 : S228 - S229
[34] Genetic counseling in patients with risk for hereditary breast cancer based on the NCCN guidelines for BRCA1/2 testing criteria in a private hospital center in Porto Alegre - Brazil
Caleffi, Maira
Perez, Yulieth Acevedo
Machado, Tabata
Sussela, Luis
Gomes, Ana Paula
Artigalas, Osvaldo
CANCER RESEARCH, 2020, 80 (04)
[35] Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Chrysafi, Pavlina
Jani, Chinmay T.
Lotz, Margaret
Al Omari, Omar
Singh, Harpreet
Stafford, Katherine
Agarwal, Lipisha
Rupal, Arashdeep
Dar, Abdul Qadir
Dangelo, Abby
Lam, Prudence
CANCERS, 2023, 15 (24)
[36] Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service
Fiorentino, Francesca
Innella, Giovanni
Balducci, Federica
Marullo, Laura
Lanzoni, Giulia
Miccoli, Sara
Cardarelli, Laura
Turchetti, Daniela
Tempesta, Sergio
FAMILIAL CANCER, 2025, 24 (01)
[37] Factors associated with genetic testing distress in patients tested for Lynch Syndrome or Hereditary Breast and Ovarian Cancer Syndrome
Margery Rosenblatt
Monica Dandapani
Rowena Mercado
Judy E Garber
Sapna Syngal
Elena M Stoffel
Hereditary Cancer in Clinical Practice, 9 (Suppl 1)
[38] Educational Needs and Preferred Methods of Learning Among Florida Practitioners Who Order Genetic Testing for Hereditary Breast and Ovarian Cancer
Cragun, Deborah
Besharat, Andrea Doty
Lewis, Courtney
Vadaparampil, Susan T.
Pal, Tuya
JOURNAL OF CANCER EDUCATION, 2013, 28 (04) : 690 - 697
[39] Educational Needs and Preferred Methods of Learning Among Florida Practitioners Who Order Genetic Testing for Hereditary Breast and Ovarian Cancer
Deborah Cragun
Andrea Doty Besharat
Courtney Lewis
Susan T. Vadaparampil
Tuya Pal
Journal of Cancer Education, 2013, 28 : 690 - 697
[40] Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis
Dancyger, Caroline
Smith, Jonathan A.
Jacobs, Chris
Wallace, Melissa
Michie, Susan
EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (12) : 1289 - 1295

← 1 2 3 4 5 →